Advanced Search

Display
per page
  Report Title Date Provider Type Pgs Price

Hikma Pharmaceuticals PLC: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis.

This report is essential reading for any serious investor, providing comprehensive financial information on a company's perfo...

12 Apr 2014 Reuters Investment Profile 12 $20.00

Thomson Reuters Stock Report - HIKMA PHARMACEUTICALS PLC (HIK-LN)

StockReports+ gathers Thomson Reuters independent research, ratings and market data into a single report that optimizes the i...

17 Apr 2014 Thomson Reuters Stock Report 11 $25.00

Wright Investors Service Comprehensive Report for Hikma Pharmaceuticals PLC

Quantitative analyses of financial statements (Income Statement, Balance Sheet and Sources of Capital), extensive ratio table...

16 Apr 2014 Wright Reports 42 $75.00

Hikma Pharmaceuticals PLC (HIK) - Financial and Strategic SWOT Analysis Review

Hikma Pharmaceuticals PLC (HIK) - Financial and Strategic SWOT Analysis Review Summary Hikma Pharmaceuticals PLC (Hikma Pharm...

11 Apr 2014 GlobalData 41 $125.00

Hikma Pharmaceuticals PLC (HIK) - Financial and Strategic SWOT Analysis Review

Hikma Pharmaceuticals PLC (HIK) - Financial and Strategic SWOT Analysis Review Summary Hikma Pharmaceuticals PLC (Hikma Pharm...

18 Mar 2014 GlobalData 41 $125.00

HIK.L - Event Transcript of Hikma Pharmaceuticals PLC conference call, Mar. 12, 2014 / 5:30AM ET

Edited Event Transcript of HIK.L conference call, Mar. 12, 2014 / 5:30AM ET London, Mar 12, 2014 (Thomson StreetEvents)...

12 Mar 2014 Thomson Reuters StreetEvents 17 $75.00

Peel Hunt: Hikma Pharmaceuticals (Hold) - Hats off

Hikma Pharmaceuticals (Hold) Hats off Hikma has announced an impressive set of results, but the injectables guidance for 20...

12 Mar 2014 Peel Hunt 3 $23.00

Hikma Pharmaceuticals PLC (HIK) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Hikma Pharmaceuticals PLC (HIK) - Pharmaceuticals & Healthcare - Deals and Alliances Profile Summary Hikma Pharmaceuticals PL...

14 Feb 2014 GlobalData 50 $250.00

Peel Hunt: Hikma Pharmaceuticals (Hold from Sell) - Strong end to FY13 for injectables

Hikma Pharmaceuticals (Hold from Sell) Strong end to FY13 for injectables Doxycycline had been the key driver of FY13 upgra...

14 Feb 2014 Peel Hunt 3 $23.00

Peel Hunt: HIK VP

Hikma Pharmaceuticals (Hold from Sell) VP (Sell)

14 Feb 2014 Peel Hunt 5 $35.00